Since hypocalcemia stimulates PTH production and decreased levels of 1,25D results in failure to inhibit PTH synthesis, an excessive rise in PTH release often accompanied by parathyroid hyperplasia, is common in CKD patients and referred as secondary hyperparathyroidism (SHPT) [36]. This evidence concerns the gene PTH and parathyroid hyperplasia.